Mutation -538 T/C in bone morphogenetic protein 4 do not increase the risk in sickle-cell disease with orthopedic complications but strongly associated with increased LDH and uric acid level in Indian patients from Chhattisgarh and Jharkhand states

Clinica Chimica Acta

Volumn 411, Issue 9-10, 2010, Pages 664-670

  Abhishek, Kumar ^a,d   Sohail, Mohammad ^b   Kumar, Ritesh ^c   Patra, P K ^a   Choudhary, S B ^d  

^a Pandit Jawaharlal Nehru Memorial Medical College   (India)

^b NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^c HAMDARD UNIVERSITY   (India)

^d VINOBA BHAVE UNIVERSITY   (India)

Author keywords

BMP4; India; LDH; Orthopedic complication; SCD

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; LACTATE DEHYDROGENASE; URIC ACID;

ARTICLE; AVASCULAR NECROSIS; BONE NECROSIS; BONE TURNOVER; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; NUCLEOTIDE SEQUENCE; ORTHOPEDICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANEMIA, SICKLE CELL; BONE DISEASES; BONE MORPHOGENETIC PROTEIN 4; CALCIUM; GENOTYPE; HEMOGLOBINS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INDIA; L-LACTATE DEHYDROGENASE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; URIC ACID;

EID: 77950461841     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.01.032     Document Type: Article

References (37)

1. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
2. Reddi A.H., Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci USA 1972, 69:1601-1605.
3. Reddi A.H. Cell biology and biochemistry of endochondral bone formation. Col Rel Res 1981, 1:209-220.
4. Urist M.R., Lietze A., Mizutani H., et al. A bovine low molecular mass bone morphogenetic protein (BMP) fraction. Clin Orthop 1982, 162:219-232.
5. Wozney J.M., Rosen V., Celeste A.J., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
6. Wang E.A., Rosen V.D., Alessandro J.S., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990, 87:2220-2224.
7. Hammonds R.G., Schwall R., Dudley A., et al. Bone-inducing activity of mature BMP-2b produced from a hybrid BMP-2a/2b precursor. Mol Endocrinol 1991, 5:149-155.
8. Riley E.H., Lane J.M., Urist M.R., Lyons K.M., Lieberman J.R. Bone morphogenetic protein-2: biology and applications. Clin Orthop Relat Res 1996, 324:39-46.
9. Lyons K.M., Pelton R.W., Hogan B.L.M. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for Bone Morphogenetic Protein-2A (BMP2A). Development 1990, 109:833-844.
10. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10:1580-1594.
11. Urist M.R., Mikulski A., Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 1979, 76:1828-1832.
12. Yamaguchi A., Ishizuya T., Kintou N., Wada Y., Katagiri T., Wozney J.M. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 1996, 220:366-371.
13. Jane J.A., Dunford B.A., Kron A., et al. Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 2002, 6:464-470.
14. Cook S.D., Rueger D.C. Osteogenic protein-1: biology and applications. Clin Orthop 1996, 29-38.
15. Hogan B.L.M. Bone morphogenetic proteins in development. Curr Opin Genet Dev 1996, 6:432-438.
16. Bellusci S., Henderson R., Winnier G., Oikawa T., Hogan B.L. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 1996, 122:1693-1702.
17. Shafritz A.B., Kaplan F.S. Differential expression of bone and cartilage related genes in fibrodysplasia ossificans progressiva, myositis ossificans traumatica, and osteogenic sarcoma. Clin Orthop 1998, 46-52.
18. Nakase T., Nomura S., Yoshikawa H., et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 1994, 9:651-659.
19. Bostrom M.P., Lane J.M., Berberian W.S., et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 1995, 13:357-367.
20. Guo X., Lee K.M., Law L.P., Chow H.K., Rosier R., Cheng C.Y. Recombinant human bone morphogenetic protein-4 (rhBMP-4) enhanced posterior spinal fusion without decortication. J Orthop Res 2002, 20:740-746.
21. Johnson E.E., Urist M.R. One-stage lengthening of femoral nonunion augmented with human bone morphogenetic protein. Clin Orthop 1998, 347:105-116.
22. Johnson E.E., Urist M.R. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop 2000, 371:61-74.
23. Diggs L.W. Bone and joint changes in sickle cell disease. Clin Orthop 1967, 52:119-143.
24. Middlemiss J.H., Raper A.B. Skeletal changes in the haemoglobinopathies. J Bone Joint Surg Br 1966, 48:693-702.
25. Li H., Li J.Z., Pittman D.D., Amalfitano A., Hankins G.R., Helm G.A. Comparison of osteogenic potentials of human rat BMP4 and BMP6 gene therapy using [E1-] and [E1-,E2b-] adenoviral vectors. Int J Med Sci 2006, 3(3):7-105.
26. Gahery-Segard H., Juillard V., Gaston J. Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts. Eur J Immunol 1997, 27:653-659.
27. Kaijzel E.L., Bayley J.P., van Krugten M.V. Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes Immun 2001, 371:508-511.
28. Ramasawmy R., Fae K.C., Spina G., et al. Association of polymorphism within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol 2007, 44:1883-1888.
29. Kato G.J., McGowan V., Machado R.F., et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006, 107:2279-2285.
30. Setty B.N., Stuart M.J., Dampier C., Brodecki D., Allen J.L. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 2003, 362:1450-1455.
31. Quinn C.T., Ahmad N. Clinical correlates of steadystate oxyhaemoglobin desaturation in children who have sickle cell disease. Br J Haematol 2005, 131:129-134.
32. Ataga K.I., Moore C.G., Jones S., Olajide O., Strayhorn D., Hinderliter A., Orringer E.P. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol 2006, 134:109-115.
33. Nduka N., Kazem Y., Saleh B. Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease. J Clin Pathol 1995, 48:648-651.
34. Judd A.M., Best K.B., Christensen K., Rodgers G.M., Bell J.D. Alterations in sensitivity to calcium and enzymatic hydrolysis of membranes from sickle cell disease and trait erythrocytes. Am J Hematol 2003, 72(3):162-169.
35. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in human against oxidant and radical-caused aging and cancer; a hypothesis. Proc Natl Acad Sci USA 1981, 78:6858-6862.
36. Tsan Z.L. Hyperuricemia associated with sickle-cell anemia may compensate for chronic antioxidant deficiency. Clin Chem 1986, 32(3):560-561.
37. Mangino M., Torrente I., De Luca A., Sanchez O., Dallapiccola B., Novelli G. A single-nucleotide polymorphism in the human bone morphogenetic protein-4 (BMP 4) gene. J Hum Genet 1999, 44:76-77.